THE ETHYLENEIMINIUM ION AS THE ACTIVE SPECIES IN 2‐HALOALKYLAMINE COMPOUNDS
Open Access
- 1 December 1957
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology and Chemotherapy
- Vol. 12 (4) , 489-497
- https://doi.org/10.1111/j.1476-5381.1957.tb00171.x
Abstract
Certain 2-haloethylamine compounds which exert antagonism to adrenaline and noradrenaline of the type shown by dibenamine have been examined. The compounds were N-ethyl-N-chlorobenzyl-2-chloroethylamine hydrochlorides in which the Cl is in the p-, o-, and m- positions of the benzene ring, and the three related ethyleneiminium picrylsulphonates. In addition the Cl- and Br- compounds of the N-ethyl-N-9-fluorenyl-2-haloethylamine hydrohalide series were examined. For the haloethylamines, a curve was provided which showed the relation between probable production and decay of ethyleneiminium ion in neutralized solution with time. A correlation was established between the shape of this curve and the curve relating anti-adrenaline and anti-noradrenaline activity of samples of solutions of these compounds treated in an identical way. The relation to antagonism of histamine and 5-hydroxytryptamine was not so exact and varied with species. The ethyleneiminium ions of the three chlorobenzyl compounds exerted a typical long-lasting non-competitive antagonism to the pressor actions of adrenaline and noradrenaline. They also antagonized the effect of 5-hydroxytryptamine and histamine on blood pressure. The ED50 of the ion when administered as ethyleneiminium picrylsulphonate was always less than the ED50 of the same ion when administered in the form of 2-haloethylamine. There was, therefore, a variable loss of effective ion during transformation in vivo. The observations throw some light on the importance of the substituent groups on the nitrogen atom for effectiveness. It is concluded from these results and a discussion of other work that 2-haloethylamine compounds form an ethyleneiminium ion in neutral solution, which is the pharmacologically active species in effective compounds. It is a necessary but not a sufficient condition that a molecule should be an alkylating agent for this type of antagonism to be present, but the importance of the substituent groups on the N atom is equally great because not all ethyleneiminium ions are effective antagonists.Keywords
This publication has 7 references indexed in Scilit:
- THE ROLE OF THE CYCLIC ETHYLENEIMINIUM ION IN THE PHARMACOLOGICAL ACTIVITY OF THE 2‐HALOETHYLAMINESBritish Journal of Pharmacology and Chemotherapy, 1954
- THE ANTIHISTAMINE AND ANTIADRENALINE PROPERTIES OF A SERIES OF N‐NAPHTHYLMETHYL‐2‐HALO‐ETHYLAMINE DERIVATIVESBritish Journal of Pharmacology and Chemotherapy, 1953
- THE CHEMICAL TRANSFORMATIONS OF DIBENAMINE AND DIBENZYLINE AND BIOLOGICAL ACTIVITY1953
- Relationship between anti-adrenaline and antihistamine activity in a series of beta-haloethylamines.1952
- THE PHYSIOLOGICAL DISPOSITION AND BIOTRANSFORMATION OF DIBENAMINE AND A METHOD FOR ITS ESTIMATION IN BIOLOGICAL TISSUES1952
- Adrenergic Blocking Agents. I. N-(9-Fluorenyl)-β-chloroethylamine Series1Journal of the American Chemical Society, 1950
- THE CHEMICAL BASIS FOR ADRENERGIC BLOCKING ACTIVITY IN COMPOUNDS RELATED TO DIBENAMINE1949